Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease

Investigator initiated trial program

ThromboGenics, Inc Investigator Initiated Trial Program

For any information about Investigator Initiated Trials (IIT), please contact us via MedicalinformationUS